Global cell & gene therapy drug delivery devices market is expected to show a robust growth in the forecast period, 2023-2027 on account of increased demand for the drug delivery devices that are quite effective in monitoring the drug dosage during the cell and gene therapies. Effective dosages would aid in maximizing the bioavailability of the drug at the target sites thus making it convenient for the patients. This factor is actively supporting the market growth in the upcoming five years. Novel drug delivery systems like subdermal implants that are available in the variants like rings and patches are boosting the global cell & gene therapy drug delivery devices market growth, in the next five years.

Moreover, number of patients suffering from chronic diseases like cancer, diabetes, and others are rising at an alarming rate. Treatment plans for such diseases require cell & gene therapy and the drug delivery devices play an important role in the treatment, thereby boosting the growth of the global cell & gene therapy drug delivery devices market in the forecast period. Government is aiding the process of increasing awareness about the devices among the patients and doctors thereby supporting the market growth.

The global cell & gene therapy drug delivery devices market is segmented by type, commercialized drugs, route of administration, method, regional distribution, and competitional landscape. Based on type the market is further fragmented into subretinal injection cannula, extension tube, intravenous catheter, sterile insulin syringe, prefilled syringe, and infusion bags. Subretinal injection cannula is anticipated to dominate the market with the largest share in the next five years.

With the introduction of the recent product launch, Luxturna, the market growth is anticipated for the intended growth. Increased FDA approval for the latest launches providing better drug delivery devices is also major factor behind the robust growth of the global cell & gene therapy drug delivery devices market.

Some of the major competitors in the market are Becton, Dickinson, and Company, Novartis AG, Amgen Inc., Kite Pharma, Inc., Pfizer, Inc., Bausch & Lomb Incorporated, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Orchard Therapeutics plc, Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation, among others. Top players have incorporated certain strategies like partnerships and investments in the research and development of the technically advanced products to excel their position in the competitive landscape of the market.

Objective of the Study:

  • To analyze the historical growth of the market size of global cell & gene therapy drug delivery devices market from 2017 to 2020.
  • To estimate and forecast the market size of global cell & gene therapy drug delivery devices market from 2021 to 2027 and growth rate until 2027. 
  • To classify and forecast global cell & gene therapy drug delivery devices market based on type, commercialized drugs, route of administration, method, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global cell & gene therapy drug delivery devices market.
  • To identify drivers and challenges for global cell & gene therapy drug delivery devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cell & gene therapy drug delivery devices market.
  • To identify and analyze the profile of leading players operating in global cell & gene therapy drug delivery devices market.
  • To identify key sustainable strategies adopted by market players in global cell & gene therapy drug delivery devices market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global cell & gene therapy drug delivery devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, service providers and other stakeholders
  • Distributers and suppliers of cell & gene therapy drug delivery devices and other stakeholders
  • Organizations, forums, and alliances related to cell & gene therapy drug delivery devices market   
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Type
  • Commercialized Drugs
  • Route of Administration
  • Method

Regional Scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa

Key Companies Profiled

Becton, Dickinson, and Company, Novartis AG, Amgen Inc., Kite Pharma, Inc., Pfizer, Inc., Bausch & Lomb Incorporated, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Orchard Therapeutics plc, Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global cell & gene therapy drug delivery devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Cell & Gene Therapy Drug Delivery Devices Market, By Type:
    • Subretinal Injection Cannula
    • Extension Tube
    • Intravenous Catheter
    • Sterile Insulin Syringe
    • Prefilled Syringe
    • Infusion Bags
  • Global Cell & Gene Therapy Drug Delivery Devices Market, By Commercialized Drugs:
    • Luxturna
    • Kymriah
    • Yescarta
    • Zolgensma
    • Provenge
    • Strimvelis
  • Global Cell & Gene Therapy Drug Delivery Devices Market, By Route of Administration:
    • Oral
    • Intravenous
    • Ocular
    • Transdermal
    • Others
  • Global Cell & Gene Therapy Drug Delivery Devices Market, By Method:
    • In Vitro
    • Ex Vivo
  • Global Cell & Gene Therapy Drug Delivery Devices Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Cell & Gene Therapy Drug Delivery Devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Cell & Gene Therapy Drug Delivery Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Cell & Gene Therapy Drug Delivery Devices Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Cell & Gene Therapy Drug Delivery Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Prefilled Syringe, Infusion Bags)

6.2.2.     By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis)

6.2.3.     By Route of Administration (Oral, Intravenous, Ocular, Transdermal, Others)

6.2.4.     By Method (In Vitro v/s Ex Vivo)

6.2.5.     By Company (2021)

6.2.6.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Cell & Gene Therapy Drug Delivery Devices Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Commercialized Drugs

7.2.3.     By Route of Administration

7.2.4.     By Method

7.2.5.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Cell & Gene Therapy Drug Delivery Devices Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Commercialized Drugs

7.3.1.2.3.             By Route of Administration

7.3.1.2.4.             By Method

7.3.2.     India Cell & Gene Therapy Drug Delivery Devices Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Commercialized Drugs

7.3.2.2.3.             By Route of Administration

7.3.2.2.4.             By Method

7.3.3.     South Korea Cell & Gene Therapy Drug Delivery Devices Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Commercialized Drugs

7.3.3.2.3.             By Route of Administration

7.3.3.2.4.             By Method

7.3.4.     Japan Cell & Gene Therapy Drug Delivery Devices Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Type

7.3.4.2.2.             By Commercialized Drugs

7.3.4.2.3.             By Route of Administration

7.3.4.2.4.             By Method

7.3.5.     Australia Cell & Gene Therapy Drug Delivery Devices Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Type

7.3.5.2.2.             By Commercialized Drugs

7.3.5.2.3.             By Route of Administration

7.3.5.2.4.             By Method

8.    Europe Cell & Gene Therapy Drug Delivery Devices Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Commercialized Drugs

8.2.3.     By Route of Administration

8.2.4.     By Method

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Cell & Gene Therapy Drug Delivery Devices Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Commercialized Drugs

8.3.1.2.3.             By Route of Administration

8.3.1.2.4.             By Method

8.3.2.     Germany Cell & Gene Therapy Drug Delivery Devices Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Commercialized Drugs

8.3.2.2.3.             By Route of Administration

8.3.2.2.4.             By Method

8.3.3.     United Kingdom Cell & Gene Therapy Drug Delivery Devices Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Commercialized Drugs

8.3.3.2.3.             By Route of Administration

8.3.3.2.4.             By Method

8.3.4.     Italy Cell & Gene Therapy Drug Delivery Devices Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Commercialized Drugs

8.3.4.2.3.             By Route of Administration

8.3.4.2.4.             By Method

8.3.5.     Spain Cell & Gene Therapy Drug Delivery Devices Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Commercialized Drugs

8.3.5.2.3.             By Route of Administration

8.3.5.2.4.             By Method

9.    North America Cell & Gene Therapy Drug Delivery Devices Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Commercialized Drugs

9.2.3.     By Route of Administration

9.2.4.     By Method

9.2.5.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Cell & Gene Therapy Drug Delivery Devices Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Commercialized Drugs

9.3.1.2.3.             By Route of Administration

9.3.1.2.4.             By Method

9.3.2.     Mexico Cell & Gene Therapy Drug Delivery Devices Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Commercialized Drugs

9.3.2.2.3.             By Route of Administration

9.3.2.2.4.             By Method

9.3.3.     Canada Cell & Gene Therapy Drug Delivery Devices Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Commercialized Drugs

9.3.3.2.3.             By Route of Administration

9.3.3.2.4.             By Method

10.  South America Cell & Gene Therapy Drug Delivery Devices Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Commercialized Drugs

10.2.3.  By Route of Administration

10.2.4.  By Method

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Cell & Gene Therapy Drug Delivery Devices Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Commercialized Drugs

10.3.1.2.3.           By Route of Administration

10.3.1.2.4.           By Method

10.3.2.  Argentina Cell & Gene Therapy Drug Delivery Devices Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Commercialized Drugs

10.3.2.2.3.           By Route of Administration

10.3.2.2.4.           By Method

10.3.3.  Colombia Cell & Gene Therapy Drug Delivery Devices Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Commercialized Drugs

10.3.3.2.3.           By Route of Administration

10.3.3.2.4.           By Method

11.  Middle East and Africa Cell & Gene Therapy Drug Delivery Devices Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Commercialized Drugs

11.2.3.  By Route of Administration

11.2.4.  By Method

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Cell & Gene Therapy Drug Delivery Devices Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Commercialized Drugs

11.3.1.2.3.           By Route of Administration

11.3.1.2.4.           By Method

11.3.2.  Saudi Arabia Cell & Gene Therapy Drug Delivery Devices Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Commercialized Drugs

11.3.2.2.3.           By Route of Administration

11.3.2.2.4.           By Method

11.3.3.  UAE Cell & Gene Therapy Drug Delivery Devices Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Commercialized Drugs

11.3.3.2.3.           By Route of Administration

11.3.3.2.4.           By Method

11.3.4.  Kuwait Cell & Gene Therapy Drug Delivery Devices Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type

11.3.4.2.2.           By Commercialized Drugs

11.3.4.2.3.           By Route of Administration

11.3.4.2.4.           By Method

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Becton, Dickinson, and Company

14.2.              Novartis AG

14.3.              Amgen Inc.

14.4.              Kite Pharma, Inc.

14.5.              Pfizer, Inc.

14.6.              Bausch & Lomb Incorporated

14.7.              Bluebird bio, Inc.

14.8.              Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)

14.9.              Dendreon Pharmaceuticals LLC.

14.10.            Helixmith Co., Ltd (ViroMed Co., Ltd)

14.11.            Orchard Therapeutics plc

14.12.            Renova Therapeutics

14.13.            Spark Therapeutics, Inc.

14.14.            uniQure N.V.

14.15.            Vericel Corporation

15.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com